UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Editorial Comment to Systemic therapy in the management of localized and locally advanced renal cell carcinoma: Current state and future perspectives

International journal of urology, 2019-05, Vol.26 (5), p.542-543

Tatsugami, Katsunori

2019

Volltextzugriff (PDF)

Editorial Comment to Renal tumors in end‐stage renal disease: A comprehensive review

International journal of urology, 2018-09, Vol.25 (9), p.786-787

Tatsugami, Katsunori

2018

Volltextzugriff (PDF)

Editorial Comment to Prediction models for progression of non‐muscle‐invasive bladder cancer: A review

International journal of urology, 2018-03, Vol.25 (3), p.218-219

Tatsugami, Katsunori

2018

Volltextzugriff (PDF)

Clinical significance of programmed death‐1 and programmed death‐ligand 1 expression in the tumor microenvironment of clear cell renal cell carcinoma

Cancer science, 2019-06, Vol.110 (6), p.1820-1828

2019

Volltextzugriff (PDF)

Immune Suppression by PD-L2 against Spontaneous and Treatment-Related Antitumor Immunity

Clinical cancer research, 2019-08, Vol.25 (15), p.4808-4819

2019

Volltextzugriff (PDF)

Evaluation of efficacy and safety of sorafenib in kidney cancer patients aged 75 years and older: a propensity score-matched analysis

British journal of cancer, 2018-07, Vol.119 (2), p.241-247

2018

Volltextzugriff (PDF)

Collateral resistance to taxanes in enzalutamide‐resistant prostate cancer through aberrant androgen receptor and its variants

Cancer science, 2018-10, Vol.109 (10), p.3224-3234

2018

Volltextzugriff (PDF)

Surgical Navigation Improves Renal Parenchyma Volume Preservation in Robot-Assisted Partial Nephrectomy: A Propensity Score Matched Comparative Analysis

The Journal of urology, 2020-07, Vol.204 (1), p.149-156

2020

Volltextzugriff (PDF)

Cabozantinib in advanced renal cell carcinoma: A phase II, open‐label, single‐arm study of Japanese patients

International journal of urology, 2020-11, Vol.27 (11), p.952-959

2020

Volltextzugriff (PDF)

Potential Role for YB-1 in Castration-Resistant Prostate Cancer and Resistance to Enzalutamide Through the Androgen Receptor V7

JNCI : Journal of the National Cancer Institute, 2016-07, Vol.108 (7), p.djw005

2016

Volltextzugriff (PDF)

A multicenter retrospective study of nivolumab monotherapy in previously treated metastatic renal cell carcinoma patients: interim analysis of Japanese real-world data

International journal of clinical oncology, 2020-08, Vol.25 (8), p.1533-1542

2020

Volltextzugriff (PDF)

Genome-wide association study of genetic variations associated with treatment failure after intravesical bacillus Calmette–Guérin therapy for non-muscle invasive bladder cancer

Cancer Immunology, Immunotherapy, 2020-07, Vol.69 (7), p.1155-1163

2020

Volltextzugriff (PDF)

Foxo3a expression and acetylation regulate cancer cell growth and sensitivity to cisplatin

Cancer science, 2010-05, Vol.101 (5), p.1177-1185

2010

Volltextzugriff (PDF)

Prognostic significance of risk stratification in CHAARTED and LATITUDE studies among Japanese men with de novo metastatic prostate cancer

International journal of urology, 2019-03, Vol.26 (3), p.426-428

2019

Volltextzugriff (PDF)

Prognostic value of programmed death-ligand 1 status in Japanese patients with renal cell carcinoma

International journal of clinical oncology, 2021-11, Vol.26 (11), p.2073-2084

2021

Volltextzugriff (PDF)

Predictive Factors for Residual Cancer in Second Transurethral Resection for Non-muscle-invasive Bladder Cancer

Anticancer research, 2019-08, Vol.39 (8), p.4325-4328

2019

Volltextzugriff (PDF)

Immunotherapy for Renal Cell Carcinoma

Clinical & developmental immunology, 2010-01, Vol.2010 (2010), p.1-8

2010

Volltextzugriff (PDF)

Predictive factors of biochemical recurrence after radical prostatectomy for high‐risk prostate cancer

International journal of urology, 2018-03, Vol.25 (3), p.284-289

2018

Volltextzugriff (PDF)

Inhibition of Protein Kinase C/Twist1 Signaling Augments Anticancer Effects of Androgen Deprivation and Enzalutamide in Prostate Cancer

Clinical cancer research, 2014-02, Vol.20 (4), p.951-961

2014

Volltextzugriff (PDF)

P300/CBP‐associated factor regulates Y‐box binding protein‐1 expression and promotes cancer cell growth, cancer invasion and drug resistance

Cancer science, 2010-08, Vol.101 (8), p.1797-1806

2010

Volltextzugriff (PDF)

Treatment patterns and outcomes in patients with unresectable or metastatic renal cell carcinoma in Japan

International journal of urology, 2019-02, Vol.26 (2), p.202-210

2019

Volltextzugriff (PDF)

Final efficacy and safety results and biomarker analysis of a phase 2 study of cabozantinib in Japanese patients with advanced renal cell carcinoma

International journal of clinical oncology, 2023-03, Vol.28 (3), p.416-426

2023

Volltextzugriff (PDF)

Assessment of surgical skills by using surgical navigation in robot-assisted partial nephrectomy

International journal for computer assisted radiology and surgery, 2019-08, Vol.14 (8), p.1449-1459

2019

Volltextzugriff (PDF)

Cigarette smoking augments androgen receptor activity and promotes resistance to antiandrogen therapy

The Prostate, 2019-07, Vol.79 (10), p.1147-1155

2019

Volltextzugriff (PDF)

The impact of genetic polymorphism on CYP19A1 in androgen-deprivation therapy among Japanese men

Cancer chemotherapy and pharmacology, 2019-05, Vol.83 (5), p.933-938

2019

Volltextzugriff (PDF)

1 – 25 von 207

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(186)
Mit Volltextzugriff
(159)

Publikationsform

Sprache

Englisch
(202)
Japanisch
(5)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

Editorial Comment to Systemic therapy in the management of localized and locally advanced renal cell carcinoma: Current state and future perspectives

Editorial Comment to Renal tumors in end‐stage renal disease: A comprehensive review

Editorial Comment to Prediction models for progression of non‐muscle‐invasive bladder cancer: A review

Clinical significance of programmed death‐1 and programmed death‐ligand 1 expression in the tumor microenvironment of clear cell renal cell carcinoma

Immune Suppression by PD-L2 against Spontaneous and Treatment-Related Antitumor Immunity

Evaluation of efficacy and safety of sorafenib in kidney cancer patients aged 75 years and older: a propensity score-matched analysis

Collateral resistance to taxanes in enzalutamide‐resistant prostate cancer through aberrant androgen receptor and its variants

Surgical Navigation Improves Renal Parenchyma Volume Preservation in Robot-Assisted Partial Nephrectomy: A Propensity Score Matched Comparative Analysis

Cabozantinib in advanced renal cell carcinoma: A phase II, open‐label, single‐arm study of Japanese patients

Potential Role for YB-1 in Castration-Resistant Prostate Cancer and Resistance to Enzalutamide Through the Androgen Receptor V7

A multicenter retrospective study of nivolumab monotherapy in previously treated metastatic renal cell carcinoma patients: interim analysis of Japanese real-world data

Genome-wide association study of genetic variations associated with treatment failure after intravesical bacillus Calmette–Guérin therapy for non-muscle invasive bladder cancer

Foxo3a expression and acetylation regulate cancer cell growth and sensitivity to cisplatin

Prognostic significance of risk stratification in CHAARTED and LATITUDE studies among Japanese men with de novo metastatic prostate cancer

Prognostic value of programmed death-ligand 1 status in Japanese patients with renal cell carcinoma

Predictive Factors for Residual Cancer in Second Transurethral Resection for Non-muscle-invasive Bladder Cancer

Immunotherapy for Renal Cell Carcinoma

Predictive factors of biochemical recurrence after radical prostatectomy for high‐risk prostate cancer

Inhibition of Protein Kinase C/Twist1 Signaling Augments Anticancer Effects of Androgen Deprivation and Enzalutamide in Prostate Cancer

P300/CBP‐associated factor regulates Y‐box binding protein‐1 expression and promotes cancer cell growth, cancer invasion and drug resistance

Treatment patterns and outcomes in patients with unresectable or metastatic renal cell carcinoma in Japan

Final efficacy and safety results and biomarker analysis of a phase 2 study of cabozantinib in Japanese patients with advanced renal cell carcinoma

Assessment of surgical skills by using surgical navigation in robot-assisted partial nephrectomy

Cigarette smoking augments androgen receptor activity and promotes resistance to antiandrogen therapy

The impact of genetic polymorphism on CYP19A1 in androgen-deprivation therapy among Japanese men

Suchergebnisse filtern